Abstract
Fourteen mothers were treated with flecainide for fetal atrial tachycardias associated with intrauterine cardiac failure. Twelve of the 14 fetuses responded by conversion to sinus rhythm. One of the 12 fetuses subsequently died in utero. The remaining fetuses suffered no morbidity and were alive and well 3 months to 2 years after delivery. The two fetuses in whom atrial tachycardia did not convert with flecainide were successfully treated with digoxin. These results compare favourably with previous forms of antiarrhythmic treatment. After recent reports of the side effects of flecainide treatment, however, it has been advised that this drug should be confined to high risk patients and those with life threatening arrhythmias. The use of flecainide for fetal arrhythmias should be limited to patients with severe fetal hydrops and supraventricular tachycardias. It should not be the first drug of choice in atrial flutter.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allan L. D., Anderson R. H., Sullivan I. D., Campbell S., Holt D. W., Tynan M. Evaluation of fetal arrhythmias by echocardiography. Br Heart J. 1983 Sep;50(3):240–245. doi: 10.1136/hrt.50.3.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arnoux P., Seyral P., Llurens M., Djiane P., Potier A., Unal D., Cano J. P., Serradimigni A., Rouault F. Amiodarone and digoxin for refractory fetal tachycardia. Am J Cardiol. 1987 Jan 1;59(1):166–167. doi: 10.1016/s0002-9149(87)80095-4. [DOI] [PubMed] [Google Scholar]
- Bergmans M. G., Jonker G. J., Kock H. C. Fetal supraventricular tachycardia. Review of the literature. Obstet Gynecol Surv. 1985 Feb;40(2):61–68. doi: 10.1097/00006254-198502000-00002. [DOI] [PubMed] [Google Scholar]
- Daffos F., Capella-Pavlovsky M., Forestier F. Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol. 1985 Nov 15;153(6):655–660. doi: 10.1016/s0002-9378(85)80254-4. [DOI] [PubMed] [Google Scholar]
- Kleinman C. S., Copel J. A., Weinstein E. M., Santulli T. V., Jr, Hobbins J. C. Treatment of fetal supraventricular tachyarrhythmias. J Clin Ultrasound. 1985 May;13(4):265–273. doi: 10.1002/jcu.1870130406. [DOI] [PubMed] [Google Scholar]
- Maxwell D. J., Crawford D. C., Curry P. V., Tynan M. J., Allan L. D. Obstetric importance, diagnosis, and management of fetal tachycardias. BMJ. 1988 Jul 9;297(6641):107–110. doi: 10.1136/bmj.297.6641.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nathan A. W., Hellestrand K. J., Bexton R. S., Spurrell R. A., Camm A. J. The proarrhythmic effects of flecainide. Drugs. 1985;29 (Suppl 4):45–53. doi: 10.2165/00003495-198500294-00010. [DOI] [PubMed] [Google Scholar]
- Shenker L. Fetal cardiac arrhythmias. Obstet Gynecol Surv. 1979 Aug;34(8):561–572. doi: 10.1097/00006254-197908000-00001. [DOI] [PubMed] [Google Scholar]
- Silverman N. H., Enderlein M. A., Stanger P., Teitel D. F., Heymann M. A., Golbus M. S. Recognition of fetal arrhythmias by echocardiography. J Clin Ultrasound. 1985 May;13(4):255–263. doi: 10.1002/jcu.1870130405. [DOI] [PubMed] [Google Scholar]
- Spinnato J. A., Shaver D. C., Flinn G. S., Sibai B. M., Watson D. L., Marin-Garcia J. Fetal supraventricular tachycardia: in utero therapy with digoxin and quinidine. Obstet Gynecol. 1984 Nov;64(5):730–735. [PubMed] [Google Scholar]
- Wren C., Campbell R. W. The response of paediatric arrhythmias to intravenous and oral flecainide. Br Heart J. 1987 Feb;57(2):171–175. doi: 10.1136/hrt.57.2.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wren C., Hunter S. Maternal administration of flecainide to terminate and suppress fetal tachycardia. Br Med J (Clin Res Ed) 1988 Jan 23;296(6617):249–249. doi: 10.1136/bmj.296.6617.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yabek S. M., Kato R., Ikeda N., Singh B. N. Effects of flecainide on the cellular electrophysiology of neonatal and adult cardiac fibers. Am Heart J. 1987 Jan;113(1):70–76. doi: 10.1016/0002-8703(87)90011-1. [DOI] [PubMed] [Google Scholar]